Teva Pharmaceutical Industries Limited (VIE:TEVA)

VIE:TEVA Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	34,083	30,497	24,154	10,588	9,478	7,769
Market Cap Growth	41.04%	26.26%	128.13%	11.71%	22.00%	-10.15%
Enterprise Value	45,681	43,180	39,874	27,443	28,328	28,089
Last Close Price	30.70	26.80	21.90	9.36	8.66	7.48
PE Ratio	28.38	25.40	-	-	-	21.19
PS Ratio	2.32	2.08	1.51	0.74	0.68	0.56
PB Ratio	5.06	4.52	4.37	1.44	1.18	0.79
P/FCF Ratio	34.86	31.19	33.39	13.90	9.72	37.44
P/OCF Ratio	24.27	21.71	20.05	8.56	6.37	11.07
EV/Sales Ratio	3.12	2.94	2.50	1.91	2.03	2.01
EV/EBITDA Ratio	10.55	13.05	9.32	7.00	7.63	7.25
EV/EBIT Ratio	13.58	17.58	12.24	9.54	11.37	10.38
EV/FCF Ratio	46.72	44.16	55.12	36.03	29.06	135.36
Debt / Equity Ratio	2.16	2.16	3.18	2.50	2.52	2.10
Debt / EBITDA Ratio	4.24	4.24	3.98	4.53	5.26	5.19
Debt / FCF Ratio	14.89	14.89	24.28	24.08	20.80	99.97
Asset Turnover	0.43	0.43	0.40	0.36	0.33	0.32
Inventory Turnover	2.69	2.69	2.41	2.09	2.08	2.02
Quick Ratio	0.54	0.54	0.50	0.54	0.57	0.61
Current Ratio	1.04	1.04	0.98	1.02	1.05	1.14
Return on Equity (ROE)	20.79%	20.79%	-28.30%	-7.36%	-25.19%	4.09%
Return on Assets (ROA)	4.50%	4.50%	5.09%	4.54%	3.63%	3.91%
Return on Invested Capital (ROIC)	13.23%	13.71%	14.73%	12.08%	8.85%	6.18%
Return on Capital Employed (ROCE)	10.60%	10.60%	12.70%	10.20%	8.20%	8.40%
Earnings Yield	3.52%	3.94%	-6.55%	-4.78%	-24.15%	4.72%
FCF Yield	2.87%	3.21%	3.00%	7.20%	10.29%	2.67%
Buyback Yield / Dilution	-2.83%	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%
Total Shareholder Return	-2.83%	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.